Epirubicin, cisplatin, and fluorouracil in gastric and esophageal cancer: a step ahead?
- PMID: 11956251
- DOI: 10.1200/JCO.2002.20.8.1962
Epirubicin, cisplatin, and fluorouracil in gastric and esophageal cancer: a step ahead?
Comment on
-
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.J Clin Oncol. 2002 Apr 15;20(8):1996-2004. doi: 10.1200/JCO.2002.08.105. J Clin Oncol. 2002. PMID: 11956258 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical